Filing Flows

Filing Flows › Iovance Biotherapeutics (IOVA) › Who owns the stock

Who owns Iovance Biotherapeutics (IOVA) stock

287 funds reported Iovance Biotherapeutics (IOVA) shares in their latest 13F filings, worth $1.3B in all. The largest holder is BlackRock ($154M). Last quarter 160 funds added to their stakes and 87 cut them.

Largest holders of IOVA (13F)Largest holders of IOVA (13F)BlackRock$154MMHR Fund Management LLC$121MState Street$102MTwo Sigma Investments, LP$79.1MVanguard Capital Management LLC$75.7MVanguard Group$74.3MVanguard Portfolio Management LLC$59.9MGeode Capital Management, LLC$43.0MMillennium Management LLC$35.5MDimensional Fund Advisors LP$26.9M

Largest holders (13F)

FundSharesValueChangeQuarter
BlackRock36,957,681$154Mincrease2026-06-30
MHR Fund Management LLC28,967,103$121Munchanged2026-06-30
State Street24,478,268$102Mincrease2026-06-30
Two Sigma Investments, LP19,010,697$79.1Mincrease2026-06-30
Vanguard Capital Management LLC18,204,248$75.7Mincrease2026-06-30
Vanguard Group27,207,079$74.3Mincrease2025-12-31
Vanguard Portfolio Management LLC14,388,999$59.9Mincrease2026-06-30
Geode Capital Management, LLC10,324,826$43.0Mincrease2026-06-30
Millennium Management LLC8,525,919$35.5Mdecrease2026-06-30
Dimensional Fund Advisors LP6,460,449$26.9Mincrease2026-06-30
Palo Alto Investors LP5,296,209$22.0Mdecrease2026-06-30
Goldman Sachs Group5,096,334$21.2Mdecrease2026-06-30
Nuveen, LLC4,997,112$20.8Mincrease2026-06-30
Bank of America4,993,584$20.8Mdecrease2026-06-30
Morgan Stanley4,986,461$20.7Mdecrease2026-06-30

Iovance Biotherapeutics' latest quarter

Iovance Biotherapeutics, Q3 2026: revenue $121M (+80% year over year), operating margin -19.7%, net loss $22.3M, operating cash flow −$4.5M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most IOVA stock?

By the latest 13F filings: BlackRock ($154M); MHR Fund Management LLC ($121M); State Street ($102M); Two Sigma Investments, LP ($79.1M); Vanguard Capital Management LLC ($75.7M).

What is the short interest in IOVA?

58,925,298 shares were sold short at the 2026-10-15 settlement, -9.1% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.